Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans.

African ancestry, Ischemic stroke, SNP, miRNA GWAS Genomics Stroke

Journal

Genome medicine

ISSN: 1756-994X

Titre abrégé: Genome Med

Pays: England

ID NLM: 101475844

Informations de publication

Date de publication:
05 Feb 2024

Historique:

received: 07 06 2023

accepted: 12 12 2023

medline: 6 2 2024

pubmed: 6 2 2024

entrez: 5 2 2024

Statut: epublish

Résumé

African ancestry populations have the highest burden of stroke worldwide, yet the genetic basis of stroke in these populations is obscure. The Stroke Investigative Research and Educational Network (SIREN) is a multicenter study involving 16 sites in West Africa. We conducted the first-ever genome-wide association study (GWAS) of stroke in indigenous Africans. Cases were consecutively recruited consenting adults (aged > 18 years) with neuroimaging-confirmed ischemic stroke. Stroke-free controls were ascertained using a locally validated Questionnaire for Verifying Stroke-Free Status. DNA genotyping with the H3Africa array was performed, and following initial quality control, GWAS datasets were imputed into the NIH Trans-Omics for Precision Medicine (TOPMed) release2 from BioData Catalyst. Furthermore, we performed fine-mapping, trans-ethnic meta-analysis, and in silico functional characterization to identify likely causal variants with a functional interpretation. We observed genome-wide significant (P-value < 5.0E-8) SNPs associations near AADACL2 and miRNA (MIR5186) genes in chromosome 3 after adjusting for hypertension, diabetes, dyslipidemia, and cardiac status in the base model as covariates. SNPs near the miRNA (MIR4458) gene in chromosome 5 were also associated with stroke (P-value < 1.0E-6). The putative genes near AADACL2, MIR5186, and MIR4458 genes were protective and novel. SNPs associations with stroke in chromosome 2 were more than 77 kb from the closest gene LINC01854 and SNPs in chromosome 7 were more than 116 kb to the closest gene LINC01446 (P-value < 1.0E-6). In addition, we observed SNPs in genes STXBP5-AS1 (chromosome 6), GALTN9 (chromosome 12), FANCA (chromosome 16), and DLGAP1 (chromosome 18) (P-value < 1.0E-6). Both genomic regions near genes AADACL2 and MIR4458 remained significant following fine mapping. Our findings identify potential roles of regulatory miRNA, intergenic non-coding DNA, and intronic non-coding RNA in the biology of ischemic stroke. These findings reveal new molecular targets that promise to help close the current gaps in accurate African ancestry-based genetic stroke's risk prediction and development of new targeted interventions to prevent or treat stroke.

Sections du résumé

BACKGROUND BACKGROUND

METHODS METHODS

Cases were consecutively recruited consenting adults (aged > 18 years) with neuroimaging-confirmed ischemic stroke. Stroke-free controls were ascertained using a locally validated Questionnaire for Verifying Stroke-Free Status. DNA genotyping with the H3Africa array was performed, and following initial quality control, GWAS datasets were imputed into the NIH Trans-Omics for Precision Medicine (TOPMed) release2 from BioData Catalyst. Furthermore, we performed fine-mapping, trans-ethnic meta-analysis, and in silico functional characterization to identify likely causal variants with a functional interpretation.

RESULTS RESULTS

We observed genome-wide significant (P-value < 5.0E-8) SNPs associations near AADACL2 and miRNA (MIR5186) genes in chromosome 3 after adjusting for hypertension, diabetes, dyslipidemia, and cardiac status in the base model as covariates. SNPs near the miRNA (MIR4458) gene in chromosome 5 were also associated with stroke (P-value < 1.0E-6). The putative genes near AADACL2, MIR5186, and MIR4458 genes were protective and novel. SNPs associations with stroke in chromosome 2 were more than 77 kb from the closest gene LINC01854 and SNPs in chromosome 7 were more than 116 kb to the closest gene LINC01446 (P-value < 1.0E-6). In addition, we observed SNPs in genes STXBP5-AS1 (chromosome 6), GALTN9 (chromosome 12), FANCA (chromosome 16), and DLGAP1 (chromosome 18) (P-value < 1.0E-6). Both genomic regions near genes AADACL2 and MIR4458 remained significant following fine mapping.

CONCLUSIONS CONCLUSIONS

Our findings identify potential roles of regulatory miRNA, intergenic non-coding DNA, and intronic non-coding RNA in the biology of ischemic stroke. These findings reveal new molecular targets that promise to help close the current gaps in accurate African ancestry-based genetic stroke's risk prediction and development of new targeted interventions to prevent or treat stroke.

Identifiants

DOI: 10.1186/s13073-023-01273-5 PMID: 38317187

pubmed: 38317187

doi: 10.1186/s13073-023-01273-5

pii: 10.1186/s13073-023-01273-5

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Akinyemi RO, Ovbiagele B, Adeniji OA, Sarfo FS, Abd-Allah F, Adoukonou T, et al. Stroke in Africa: profile, progress, prospects and priorities. Nat Rev Neurol. 2021;17(10):634–56.

pubmed: 34526674 pmcid: 8441961 doi: 10.1038/s41582-021-00542-4

Owolabi MO, Akarolo-Anthony S, Akinyemi R, Arnett D, Gebregziabher M, Jenkins C, et al. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr. 2015;26(2 Suppl 1):S27–38.

pubmed: 25962945 pmcid: 4557491 doi: 10.5830/CVJA-2015-038

Kamin Mukaz D, Zakai NA, Cruz-Flores S, McCullough LD, Cushman M. Identifying genetic and biological determinants of race-ethnic disparities in stroke in the United States. Stroke. 2020;51(11):3417–24.

pubmed: 33104469 doi: 10.1161/STROKEAHA.120.030425

Gardener H, Sacco RL, Rundek T, Battistella V, Cheung YK, Elkind MSV. Race and ethnic disparities in stroke incidence in the Northern Manhattan Study. Stroke. 2020;51(4):1064–9.

pubmed: 32078475 pmcid: 7093213 doi: 10.1161/STROKEAHA.119.028806

Collaborators GBDN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.

doi: 10.1016/S1474-4422(18)30499-X

Owolabi M, Sarfo F, Howard VJ, Irvin MR, Gebregziabher M, Akinyemi R, et al. Stroke in Indigenous Africans, African Americans, and European Americans: interplay of racial and geographic factors. Stroke. 2017;48(5):1169–75.

pubmed: 28389611 pmcid: 5404953 doi: 10.1161/STROKEAHA.116.015937

Akinyemi RO, Ovbiagele B, Akpalu A, Jenkins C, Sagoe K, Owolabi L, et al. Stroke genomics in people of African ancestry: charting new paths. Cardiovasc J Afr. 2015;26(2 Suppl 1):S39–49.

pubmed: 25962947 pmcid: 4557488 doi: 10.5830/CVJA-2015-039

Keene KL, Hyacinth HI, Bis JC, Kittner SJ, Mitchell BD, Cheng YC, et al. Genome-wide association study meta-analysis of stroke in 22 000 individuals of African descent identifies novel associations with stroke. Stroke. 2020;51(8):2454–63.

pubmed: 32693751 pmcid: 7387190 doi: 10.1161/STROKEAHA.120.029123

Carty CL, Keene KL, Cheng YC, Meschia JF, Chen WM, Nalls M, et al. Meta-analysis of genome-wide association studies identifies genetic risk factors for stroke in African Americans. Stroke. 2015;46(8):2063–8.

pubmed: 26089329 pmcid: 4740911 doi: 10.1161/STROKEAHA.115.009044

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524–37.

pubmed: 29531354 pmcid: 5968830 doi: 10.1038/s41588-018-0058-3

Dichgans M, Pulit SL, Rosand J. Stroke genetics: discovery, biology, and clinical applications. Lancet Neurol. 2019;18(6):587–99.

pubmed: 30975520 doi: 10.1016/S1474-4422(19)30043-2

Rotimi CN, Tekola-Ayele F, Baker JL, Shriner D. The African diaspora: history, adaptation and health. Curr Opin Genet Dev. 2016;41:77–84.

pubmed: 27644073 pmcid: 5318189 doi: 10.1016/j.gde.2016.08.005

Adeyemo AA, Zaghloul NA, Chen G, Doumatey AP, Leitch CC, Hostelley TL, et al. ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response. Nat Commun. 2019;10(1):3195.

pubmed: 31324766 pmcid: 6642147 doi: 10.1038/s41467-019-10967-7

Akinyemi RO, Owolabi MO, Ihara M, Damasceno A, Ogunniyi A, Dotchin C, et al. Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa. Brain Res Bull. 2018;145:97–108.

pubmed: 29807146 pmcid: 6252289 doi: 10.1016/j.brainresbull.2018.05.018

Owolabi M, Peprah E, Xu H, Akinyemi R, Tiwari HK, Irvin MR, et al. Advancing stroke genomic research in the age of Trans-Omics big data science: emerging priorities and opportunities. J Neurol Sci. 2017;382:18–28.

pubmed: 29111012 pmcid: 5685670 doi: 10.1016/j.jns.2017.09.021

Tishkoff SA, Goldman A, Calafell F, Speed WC, Deinard AS, Bonne-Tamir B, et al. A global haplotype analysis of the myotonic dystrophy locus: implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations. Am J Hum Genet. 1998;62(6):1389–402.

pubmed: 9585589 pmcid: 1377140 doi: 10.1086/301861

Consortium HA, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, et al. Research capacity. Enabling the genomic revolution in Africa. Science. 2014;344(6190):1346–8.

doi: 10.1126/science.1251546

Choudhury A, Aron S, Botigue LR, Sengupta D, Botha G, Bensellak T, et al. High-depth African genomes inform human migration and health. Nature. 2020;586(7831):741–8.

pubmed: 33116287 pmcid: 7759466 doi: 10.1038/s41586-020-2859-7

Mishra A, Malik R, Hachiya T, Jurgenson T, Namba S, Posner DC, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115–23.

pubmed: 36180795 pmcid: 9524349 doi: 10.1038/s41586-022-05165-3

Owolabi MO, Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B. SIREN Team; as part of H3Africa Consortium. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health. 2018;6(4):e436–46.

Crawford KM, Gallego-Fabrega C, Kourkoulis C, Miyares L, Marini S, Flannick J, et al. Cerebrovascular disease knowledge portal: an open-access data resource to accelerate genomic discoveries in stroke. Stroke. 2018;49(2):470–5.

pubmed: 29335331 pmcid: 5780219 doi: 10.1161/STROKEAHA.117.018922

Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826.

pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5

Watanabe K, Umicevic Mirkov M, de Leeuw CA, van den Heuvel MP, Posthuma D. Genetic mapping of cell type specificity for complex traits. Nat Commun. 2019;10(1):3222.

pubmed: 31324783 pmcid: 6642112 doi: 10.1038/s41467-019-11181-1

Akpalu A, Sarfo FS, Ovbiagele B, Akinyemi R, Gebregziabher M, Obiako R, et al. Phenotyping stroke in Sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) phenomics protocol. Neuroepidemiology. 2015;45(2):73–82.

pubmed: 26304844 doi: 10.1159/000437372

Akinyemi R, Arnett DK, Tiwari HK, Ovbiagele B, Sarfo F, Srinivasasainagendra V, et al. Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men. J Neurol Sci. 2017;379:229–35.

pubmed: 28716248 pmcid: 5546618 doi: 10.1016/j.jns.2017.05.046

Sarfo F, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, et al. Multilingual validation of the questionnaire for verifying stroke-free status in West Africa. Stroke. 2016;47(1):167–72.

pubmed: 26578660 doi: 10.1161/STROKEAHA.115.010374

Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2(12):e190. https://doi.org/10.1371/journal.pgen.0020190 .

doi: 10.1371/journal.pgen.0020190 pubmed: 17194218 pmcid: 1713260

Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9. https://doi.org/10.1038/ng1847 .

doi: 10.1038/ng1847 pubmed: 16862161

Browning BL, Tian X, Zhou Y, Browning SR. Fast two-stage phasing of large-scale sequence data. Am J Hum Genet. 2021;108(10):1880–90. https://doi.org/10.1016/j.ajhg.2021.08.005 .

doi: 10.1016/j.ajhg.2021.08.005 pubmed: 34478634 pmcid: 8551421

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75. https://doi.org/10.1086/519795 .

doi: 10.1086/519795 pubmed: 17701901 pmcid: 1950838

Han B, Eskin E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet. 2011;88(5):586–98.

pubmed: 21565292 pmcid: 3146723 doi: 10.1016/j.ajhg.2011.04.014

Morris AP. Transethnic meta-analysis of genomewide association studies. Genet Epidemiol. 2011;35(8):809–22.

pubmed: 22125221 pmcid: 3460225 doi: 10.1002/gepi.20630

Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190–1.

pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340

Kichaev G, Yang WY, Lindstrom S, Hormozdiari F, Eskin E, Price AL, et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014;10(10):e1004722.

pubmed: 25357204 pmcid: 4214605 doi: 10.1371/journal.pgen.1004722

Glasziou PP, Shepperd S, Brassey J. Can we rely on the best trial? A comparison of individual trials and systematic reviews. BMC Med Res Methodol. 2010;10:23.

pubmed: 20298582 pmcid: 2851704 doi: 10.1186/1471-2288-10-23

Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal HM, Lough F, et al. Exercise-based rehabilitation for heart failure: systematic review and meta-analysis. Open Heart. 2015;2(1):e000163.

pubmed: 25685361 pmcid: 4316592 doi: 10.1136/openhrt-2014-000163

Toulza E, Mattiuzzo NR, Galliano MF, Jonca N, Dossat C, Jacob D, et al. Large-scale identification of human genes implicated in epidermal barrier function. Genome Biol. 2007;8(6):R107.

pubmed: 17562024 pmcid: 2394760 doi: 10.1186/gb-2007-8-6-r107

Xu H, Dorn GW 2nd, Shetty A, Parihar A, Dave T, Robinson SW, et al. A genome-wide association study of idiopathic dilated cardiomyopathy in African Americans. J Pers Med. 2018;8(1):11.

pubmed: 29495422 pmcid: 5872085 doi: 10.3390/jpm8010011

Howard SR, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr HL, et al. IGSF10 mutations dysregulate gonadotropin-releasing hormone neuronal migration resulting in delayed puberty. EMBO Mol Med. 2016;8(6):626–42.

pubmed: 27137492 pmcid: 4888853 doi: 10.15252/emmm.201606250

Debette S, Ibrahim Verbaas CA, Bressler J, Schuur M, Smith A, Bis JC, et al. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Biol Psychiatry. 2015;77(8):749–63.

pubmed: 25648963 doi: 10.1016/j.biopsych.2014.08.027

Bonder MJ, Tigchelaar EF, Cai X, Trynka G, Cenit MC, Hrdlickova B, et al. The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med. 2016;8(1):45.

pubmed: 27102333 pmcid: 4841035 doi: 10.1186/s13073-016-0295-y

Evans KL, Wirtz HS, Li J, She R, Maya J, Gui H, et al. Genetics of heart rate in heart failure patients (GenHRate). Hum Genomics. 2019;13(1):22.

pubmed: 31113495 pmcid: 6528282 doi: 10.1186/s40246-019-0206-6

Divers J, Palmer ND, Langefeld CD, Brown WM, Lu L, Hicks PJ, et al. Genome-wide association study of coronary artery calcified atherosclerotic plaque in African Americans with type 2 diabetes. BMC Genet. 2017;18(1):105.

pubmed: 29221444 pmcid: 5723099 doi: 10.1186/s12863-017-0572-9

Yang M, Zhang J, Jin X, Li C, Zhou G, Feng J. NRF1-enhanced miR-4458 alleviates cardiac hypertrophy through releasing TTP-inhibited TFAM. In Vitro Cell Dev Biol Anim. 2020;56(2):120–8.

pubmed: 31942725 doi: 10.1007/s11626-019-00419-3

Ou J, Kou L, Liang L, Tang C. MiR-375 attenuates injury of cerebral ischemia/reperfusion via targetting Ctgf. Biosci Rep. 2017;37(6).

Yang G, Liu Z, Wang L, Chen X, Wang X, Dong Q, et al. MicroRNA-195 protection against focal cerebral ischemia by targeting CX3CR1. J Neurosurg. 2018;131(5):1445–54.

doi: 10.3171/2018.5.JNS173061

Shan Y, Hu J, Lv H, Cui X, Di W. miR-221 exerts neuroprotective effects in ischemic stroke by inhibiting the proinflammatory response. J Stroke Cerebrovasc Dis. 2021;30(2):105489.

pubmed: 33276305 doi: 10.1016/j.jstrokecerebrovasdis.2020.105489

Li L, Voloboueva L, Griffiths BB, Xu L, Giffard RG, Stary CM. MicroRNA-338 inhibition protects against focal cerebral ischemia and preserves mitochondrial function in vitro in astrocytes and neurons via COX4I1. Mitochondrion. 2021;59:105–12.

pubmed: 33933660 pmcid: 8292173 doi: 10.1016/j.mito.2021.04.013

Dias A, Silva L, Moura J, Gabriel D, Maia LF. Fluid biomarkers in stroke: from animal models to clinical care. Acta Neurol Scand. 2022;146(4):332–47.

pubmed: 35838031 doi: 10.1111/ane.13668

Kadir RRA, Alwjwaj M, Bayraktutan U. MicroRNA: an emerging predictive, diagnostic, prognostic and therapeutic strategy in ischaemic stroke. Cell Mol Neurobiol. 2022;42(5):1301–19.

pubmed: 33368054 doi: 10.1007/s10571-020-01028-5

Li K, Shen L, Zheng P, Wang Y, Wang L, Meng X, et al. Identification of MicroRNAs as potential biomarkers for detecting ischemic stroke. Genes Genomics. 2022;44(1):9–17.

pubmed: 33818699 doi: 10.1007/s13258-021-01060-9

Goffinet M, Tardy C, Boubekeur N, Cholez G, Bluteau A, Oniciu DC, et al. P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo. PLoS One. 2014;9(4):e95807.

pubmed: 24769858 pmcid: 4000210 doi: 10.1371/journal.pone.0095807

Miras-Portugal MT, Queipo MJ, Gil-Redondo JC, Ortega F, Gomez-Villafuertes R, Gualix J, et al. P2 receptor interaction and signalling cascades in neuroprotection. Brain Res Bull. 2019;151:74–83.

pubmed: 30593879 doi: 10.1016/j.brainresbull.2018.12.012

Perez-Sen R, Gomez-Villafuertes R, Ortega F, Gualix J, Delicado EG, Miras-Portugal MT. An update on P2Y13 receptor signalling and function. Adv Exp Med Biol. 2017;1051:139–68.

pubmed: 28815513 doi: 10.1007/5584_2017_91

Gu Q, Xu F, Orgil BO, Khuchua Z, Munkhsaikhan U, Johnson JN, et al. Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways. Physiol Genomics. 2022;54(1):22–35.

pubmed: 34766515 doi: 10.1152/physiolgenomics.00066.2021

Gu Q, Xu F, Orgil BO, Khuchua Z, Munkhsaikhan U, Johnson JN, Alberson NR, Pierre JF, Black DD, Dong D, Brennan JA, Cathey BM, Efimov IR, Towbin JA, Purevjav E, Lu L. Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways. Physiol Genomics. 2022;54(1):22–35.

Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling GC, et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol. 2020;16(5):247–64.

pubmed: 32322099 doi: 10.1038/s41582-020-0350-6

Mosley JD, Gupta DK, Tan J, Yao J, Wells QS, Shaffer CM, et al. Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease. JAMA. 2020;323(7):627–35.

pubmed: 32068817 pmcid: 7042849 doi: 10.1001/jama.2019.21782

Studies N-NWGoRiA, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. Replicating genotype-phenotype associations. Nature. 2007;447(7145):655–60.

doi: 10.1038/447655a

Shriner D, Adeyemo A, Gerry NP, Herbert A, Chen G, Doumatey A, et al. Transferability and fine-mapping of genome-wide associated loci for adult height across human populations. PLoS One. 2009;4(12):e8398.

pubmed: 20027299 pmcid: 2792725 doi: 10.1371/journal.pone.0008398

Gharahkhani P, Jorgenson E, Hysi P, Khawaja AP, Pendergrass S, Han X, et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat Commun. 2021;12(1):1258.

pubmed: 33627673 pmcid: 7904932 doi: 10.1038/s41467-020-20851-4

Choudhury A, Brandenburg JT, Chikowore T, Sengupta D, Boua PR, Crowther NJ, et al. Author Correction: Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits. Nat Commun. 2022;13(1):4474.

pubmed: 35918347 pmcid: 9345983 doi: 10.1038/s41467-022-32072-y

Machipisa T, Chong M, Muhamed B, Chishala C, Shaboodien G, Pandie S, et al. Association of novel locus with rheumatic heart disease in Black African individuals: findings from the RHDGen study. JAMA Cardiol. 2021;6(9):1000–11.

pubmed: 34106200 pmcid: 8190704 doi: 10.1001/jamacardio.2021.1627